Neuwelt EA - Search Results

1

Immunologic privilege in the central nervous system and the blood-brain barrier.

Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR, Prat A, Scarpa M, Smeyne RJ, Drewes LR, Neuwelt EA. Muldoon LL, et al. Among authors: neuwelt ea. J Cereb Blood Flow Metab. 2013 Jan;33(1):13-21. doi: 10.1038/jcbfm.2012.153. Epub 2012 Oct 17. J Cereb Blood Flow Metab. 2013. PMID: 23072749 Free PMC article. Review.

2

Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy.

Crossen JR, Goldman DL, Dahlborg SA, Neuwelt EA. Crossen JR, et al. Among authors: neuwelt ea. Neurosurgery. 1992 Jan;30(1):23-9. doi: 10.1227/00006123-199201000-00005. Neurosurgery. 1992. PMID: 1738451

3

Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.

Muldoon LL, Nilaver G, Kroll RA, Pagel MA, Breakefield XO, Chiocca EA, Davidson BL, Weissleder R, Neuwelt EA. Muldoon LL, et al. Among authors: neuwelt ea. Am J Pathol. 1995 Dec;147(6):1840-51. Am J Pathol. 1995. PMID: 7495307 Free PMC article.

4

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.

Nilaver G, Muldoon LL, Kroll RA, Pagel MA, Breakefield XO, Davidson BL, Neuwelt EA. Nilaver G, et al. Among authors: neuwelt ea. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9829-33. doi: 10.1073/pnas.92.21.9829. Proc Natl Acad Sci U S A. 1995. PMID: 7568227 Free PMC article.

5

Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease).

Muldoon LL, Neuwelt EA, Pagel MA, Weiss DL. Muldoon LL, et al. Among authors: neuwelt ea. Am J Pathol. 1994 May;144(5):1109-18. Am J Pathol. 1994. PMID: 8178934 Free PMC article.

6

In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity.

Neuwelt EA, Brummett RE, Remsen LG, Kroll RA, Pagel MA, McCormick CI, Guitjens S, Muldoon LL. Neuwelt EA, et al. Cancer Res. 1996 Feb 15;56(4):706-9. Cancer Res. 1996. PMID: 8630999

7

Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.

Kroll RA, Pagel MA, Muldoon LL, Roman-Goldstein S, Neuwelt EA. Kroll RA, et al. Among authors: neuwelt ea. Neurosurgery. 1996 Apr;38(4):746-52; discussion 752-4. Neurosurgery. 1996. PMID: 8692395

8

The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.

Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA. Dahlborg SA, et al. Among authors: neuwelt ea. Cancer J Sci Am. 1998 Mar-Apr;4(2):110-24. Cancer J Sci Am. 1998. PMID: 9532413

9

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

Kroll RA, Neuwelt EA. Kroll RA, et al. Among authors: neuwelt ea. Neurosurgery. 1998 May;42(5):1083-99; discussion 1099-100. doi: 10.1097/00006123-199805000-00082. Neurosurgery. 1998. PMID: 9588554 Review.

10

First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.

Neuwelt EA, Brummett RE, Doolittle ND, Muldoon LL, Kroll RA, Pagel MA, Dojan R, Church V, Remsen LG, Bubalo JS. Neuwelt EA, et al. J Pharmacol Exp Ther. 1998 Jul;286(1):77-84. J Pharmacol Exp Ther. 1998. PMID: 9655844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page